Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-22

Clinical Trial Update: Study to Investigate the Mechanism of Action of an Oral Enzyme Treatment With Bromelain, Trypsin and Rutoside Versus Placebo in Subjects With OsTeoarthritis [NA]

View source ↗

Summary

An clinical trial evaluated the mechanism of action of an oral enzyme treatment consisting of bromelain, trypsin, and rutoside versus placebo in osteoarthritis.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromelain, Trypsin and Rutoside combination (bromelain; trypsin; rutoside)

Snippet

Sponsor: Mucos Pharma GmbH & Co. KG | Conditions: Osteoarthritis | NA | Status: COMPLETED